المؤلفون: Nassar, ZD, Mah, CY, Dehairs, J, Burvenich, Ingrid, Irani, S, Centenera, MM, Helm, M, Shrestha, RK, Moldovan, M, Don, AS, Holst, J, Scott, Andrew, Horvath, LG, Lynn, DJ, Selth, LA, Hoy, AJ, Swinnen, JV, Butler, LM

مصطلحات موضوعية: food and beverages, 3. Good health, Uncategorized

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7747ebd564a13ebd0b1816ac70cb82b2

المؤلفون: Shrestha RK; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Nassar ZD; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Hanson AR; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Iggo R; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Institut Bergonié Unicancer, INSERM, Bordeaux, France., Townley SL; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Dehairs J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Mah CY; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Helm M; South Australian Health and Medical Research Institute, Adelaide, Australia., Alizadeh-Ghodsi M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Pickering M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Ghesquière B; Metabolomics Core Facility Leuven, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Watt MJ; Department of Physiology, University of Melbourne, Melbourne, Australia., Quek LE; School of Mathematics and Statistics, Charles Perkins Centre, Faculty of Science, The University of Sydney, Camperdown, Australia., Hoy AJ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Butler LM; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Selth LA; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia.

المصدر: Cancer research [Cancer Res] 2024 Jul 15; Vol. 84 (14), pp. 2313-2332.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/genetics , Coenzyme A Ligases*/metabolism , Coenzyme A Ligases*/genetics , Ferroptosis* , Fatty Acids*/metabolism , Cell Proliferation*, Male ; Humans ; Animals ; Mice ; Cell Line, Tumor ; Receptors, Androgen/metabolism ; Lipid Metabolism ; Xenograft Model Antitumor Assays

المؤلفون: Mah CY; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Nguyen ADT; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Niijima T; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia., Helm M; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Dehairs J; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Ryan FJ; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia., Ryan N; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Quek LE; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006, Australia., Hoy AJ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006, Australia., Don AS; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006, Australia., Mills IG; Patrick G Johnston Centre for Cancer Research, Queen's University, Belfast, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Swinnen JV; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Lynn DJ; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia., Nassar ZD; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia. zeyad.nassar@adelaide.edu.au.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia. zeyad.nassar@adelaide.edu.au., Butler LM; South Australian Immunogenomics Cancer Institute and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia. lisa.butler@adelaide.edu.au.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia. lisa.butler@adelaide.edu.au.

المصدر: British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 741-754. Date of Electronic Publication: 2024 Jan 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/genetics , Prostatic Neoplasms, Castration-Resistant*/metabolism, Male ; Humans ; Lipid Metabolism/genetics ; Cell Line, Tumor ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Androgens/metabolism ; Cell Proliferation ; Fatty Acids

المؤلفون: Scott JS; South Australian ImmunoGENomics Cancer Institute, Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5005, Australia; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia., Quek LE; School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, 2006, Australia., Hoy AJ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia., Swinnen JV; LKI - Leuven Cancer Institute, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, B-3000, Belgium., Nassar ZD; South Australian ImmunoGENomics Cancer Institute, Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5005, Australia; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia., Butler LM; South Australian ImmunoGENomics Cancer Institute, Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5005, Australia; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia. Electronic address: lisa.butler@adelaide.edu.au.

المصدر: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Jan 08; Vol. 691, pp. 149273. Date of Electronic Publication: 2023 Nov 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Malonyl Coenzyme A*/metabolism , Malonyl Coenzyme A*/pharmacology , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/metabolism, Male ; Humans ; Cell Survival ; Fatty Acids/metabolism ; Mitochondria/metabolism ; Oxidation-Reduction ; Carnitine O-Palmitoyltransferase/metabolism

المؤلفون: Hinneh JA; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Gillis JL; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Mah CY; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Irani S; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Shrestha RK; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia.; College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, 5042, Australia., Ryan NK; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Atsushi E; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Nassar ZD; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Lynn DJ; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia., Selth LA; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia.; College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, 5042, Australia., Kato M; Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Centenera MM; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia., Butler LM; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia. lisa.butler@adelaide.edu.au.; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia. lisa.butler@adelaide.edu.au.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia. lisa.butler@adelaide.edu.au.; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia. lisa.butler@adelaide.edu.au.

المصدر: British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (8), pp. 1350-1361. Date of Electronic Publication: 2023 Sep 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms, Castration-Resistant*/drug therapy, Male ; Humans ; Mice ; Animals ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Cell Line, Tumor ; Nitriles/pharmacology ; RNA, Small Interfering/pharmacology ; Drug Resistance, Neoplasm/genetics ; Cell Proliferation

المؤلفون: Scott JS; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Nassar ZD; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Swinnen JV; LKI - Leuven Cancer Institute, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Butler LM; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.

المصدر: Molecular cancer research : MCR [Mol Cancer Res] 2022 Sep 02; Vol. 20 (9), pp. 1354-1364.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Fatty Acids, Monounsaturated*/metabolism , Fatty Acids, Monounsaturated*/pharmacology , Neoplasms*/genetics, Cell Survival ; Fatty Acids ; Humans ; Signal Transduction

المؤلفون: Raftopulos NL; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Washaya TC; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Niederprüm A; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine, Ruprecht Karl University of Heidelberg, Baden-Wuerttemberg, Heidelberg, Germany., Egert A; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Hakeem-Sanni MF; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Varney B; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Aishah A; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Georgieva ML; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Olsson E; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Dos Santos DZ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espirito Santo, Vitoria, ES, Brazil., Nassar ZD; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, South Australia, Australia.; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia., Cochran BJ; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Nagarajan SR; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Kakani MS; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Hastings JF; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Croucher DR; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St Vincent's Hospital Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Rye KA; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Butler LM; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, South Australia, Australia.; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia., Grewal T; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Hoy AJ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. andrew.hoy@sydney.edu.au.

المصدر: Cancer & metabolism [Cancer Metab] 2022 Jan 15; Vol. 10 (1), pp. 1. Date of Electronic Publication: 2022 Jan 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101607582 Publication Model: Electronic Cited Medium: Print ISSN: 2049-3002 (Print) Linking ISSN: 20493002 NLM ISO Abbreviation: Cancer Metab Subsets: PubMed not MEDLINE

المؤلفون: Butler LM; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia. lisa.butler@adelaide.edu.au.; South Australian Health and Medical Research Institute, Adelaide, Australia., Mah CY; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Machiels J; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Vincent AD; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Irani S; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Mutuku SM; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Spotbeen X; South Australian Health and Medical Research Institute, Adelaide, Australia.; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Bagadi M; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Waltregny D; Department of Urology, University Hospital of Liège, Liege, Belgium., Moldovan M; South Australian Health and Medical Research Institute, Adelaide, Australia., Dehairs J; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Vanderhoydonc F; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Bloch K; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Das R; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; Dame Roma Mitchell Cancer Research Laboratories, University of Adelaide, Adelaide, Australia.; Northwestern University, Feinberg School of Medicine, Comprehensive Transplant Center, Chicago, Illinois., Stahl J; Clinpath Laboratories, Adelaide, Australia., Kench JG; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, New South Wales, Australia.; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.; University of Sydney, Camperdown, New South Wales, Australia., Gevaert T; Department of Urology, UZ Leuven, Leuven, Belgium., Derua R; Department of Cellular and Molecular Medicine and SyBioMa Center, KU Leuven, Leuven, Belgium., Waelkens E; Department of Cellular and Molecular Medicine and SyBioMa Center, KU Leuven, Leuven, Belgium., Nassar ZD; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Selth LA; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; Dame Roma Mitchell Cancer Research Laboratories, University of Adelaide, Adelaide, Australia.; Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia., Trim PJ; South Australian Health and Medical Research Institute, Adelaide, Australia., Snel MF; South Australian Health and Medical Research Institute, Adelaide, Australia., Lynn DJ; South Australian Health and Medical Research Institute, Adelaide, Australia.; Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia., Tilley WD; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; Dame Roma Mitchell Cancer Research Laboratories, University of Adelaide, Adelaide, Australia., Horvath LG; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.; University of Sydney, Camperdown, New South Wales, Australia.; Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; University of New South Wales, Sydney, New South Wales, Australia., Centenera MM; Adelaide Medical School and Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.

المصدر: Cancer research [Cancer Res] 2021 Oct 01; Vol. 81 (19), pp. 4981-4993. Date of Electronic Publication: 2021 Aug 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Lipid Metabolism*/drug effects , Lipidomics*/methods, Membrane Lipids/*metabolism , Prostatic Neoplasms/*metabolism, Biomarkers ; Computational Biology/methods ; Energy Metabolism ; Humans ; Male ; Metabolomics/methods ; Molecular Targeted Therapy ; Neoplasm Grading ; Neoplasm Staging ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/etiology ; Spectrometry, Mass, Electrospray Ionization ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Tandem Mass Spectrometry ; Transcriptional Regulator ERG/genetics ; Transcriptional Regulator ERG/metabolism

المؤلفون: Centenera MM; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Scott JS; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Machiels J; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Nassar ZD; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Miller DC; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Zinonos I; University of Adelaide Medical School, Adelaide, SA, Australia.; Basil Hetzel Institute, Queen Elizabeth Hospital, SA, Australia., Dehairs J; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Zadra G; Dana-Farber Cancer Institute, Boston, Massachusetts., Chetta PM; Dana-Farber Cancer Institute, Boston, Massachusetts.; University of Milan, Milan, Italy., Bango C; Dana-Farber Cancer Institute, Boston, Massachusetts., Evergren E; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Ryan NK; University of Adelaide Medical School, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Gillis JL; University of Adelaide Medical School, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Mah CY; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Tieu T; Drug Delivery, Disposition and Dynamics, Monash University, Parkville, VIC, Australia.; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia., Hanson AR; University of Adelaide Medical School, Adelaide, SA, Australia., Carelli R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York., Bloch K; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Panagopoulos V; University of Adelaide Medical School, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Waelkens E; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Derua R; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Williams ED; Australian Prostate Cancer Research Centre - Queensland, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD, Australia., Evdokiou A; University of Adelaide Medical School, Adelaide, SA, Australia.; Basil Hetzel Institute, Queen Elizabeth Hospital, SA, Australia., Cifuentes-Rius A; Drug Delivery, Disposition and Dynamics, Monash University, Parkville, VIC, Australia., Voelcker NH; Drug Delivery, Disposition and Dynamics, Monash University, Parkville, VIC, Australia.; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia.; Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, Clayton, VIC, Australia., Mills IG; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Tilley WD; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York., Selth LA; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Swinnen JV; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium. lisa.butler@adelaide.edu.au j.swinnen@kuleuven.be., Butler LM; University of Adelaide Medical School, Adelaide, SA, Australia. lisa.butler@adelaide.edu.au j.swinnen@kuleuven.be.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.

المصدر: Cancer research [Cancer Res] 2021 Apr 01; Vol. 81 (7), pp. 1704-1718. Date of Electronic Publication: 2021 Feb 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Fatty Acid Elongases/*antagonists & inhibitors , Prostatic Neoplasms/*drug therapy , RNA, Small Interfering/*therapeutic use, Animals ; Cell Movement/drug effects ; Cell Movement/genetics ; Cell Proliferation/drug effects ; Cell Proliferation/genetics ; Fatty Acid Elongases/genetics ; Fatty Acid Elongases/physiology ; Gene Expression Regulation, Enzymologic/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Knockdown Techniques ; Humans ; Lipid Metabolism/genetics ; Male ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Molecular Targeted Therapy/methods ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; RNA, Small Interfering/pharmacology ; Receptors, Androgen/physiology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

المؤلفون: Hammad HM; Department of Biological Sciences, School of Science, The University of Jordan, Amman,Jordan., Imraish A; Department of Biological Sciences, School of Science, The University of Jordan, Amman,Jordan., Al-Hussaini M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center (KHCC), Amman,Jordan., Zihlif M; Department of Pharmacology, School of Medicine, The University of Jordan, Amman,Jordan., Harb AA; Department of Basic Sciences, Faculty of Arts and Sciences, Al-Ahliyya Amman University, Amman,Jordan., Abu Thiab TM; Department of Biological Sciences, School of Science, The University of Jordan, Amman,Jordan., Lafi Z; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman,Jordan., Nassar ZD; School of Medicine and Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, South Australia,Australia., Afifi FU; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman,Jordan.

المصدر: Endocrine, metabolic & immune disorders drug targets [Endocr Metab Immune Disord Drug Targets] 2021; Vol. 21 (11), pp. 2035-2042.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101269157 Publication Model: Print Cited Medium: Internet ISSN: 2212-3873 (Electronic) Linking ISSN: 18715303 NLM ISO Abbreviation: Endocr Metab Immune Disord Drug Targets Subsets: MEDLINE

مواضيع طبية MeSH: Achillea*/chemistry , Neovascularization, Physiologic* , Plant Extracts*/pharmacology , Wound Healing*, Animals ; Ethanol ; Rats ; Vascular Endothelial Growth Factor A/metabolism